Price of J&J’s TB drug to drop by more than half
In what will come as good news for tuberculosis (TB) patients, life-saving drug bedaquiline by US pharma company Johnson & Johnson (J&J) is now being offered at $400 per patient…
Jubilant Life Sciences plans Rs 550-cr capex in FY19
MUMBAI: Pharma company Jubilant Life Sciences has earmarked Rs 550 crore for capital expenditure (capex) in the current financial year, a top company official said. It is also planning to…
Illegal internet drugs pharmacy busted in Delhi, 4 held
New Delhi: An illegal internet pharmacy, allegedly shipping drugs to overseas locations like the US and Canada, based in Delhi has been busted by the NCB with the apprehension of…
Mumbai: Thane doctor loses licence for six months for ethics breach
MUMBAI: The licence of a Thane pathologist has been suspended for six months for his alleged association, in terms of lending his name and registration number, to nearly a hundred…
Serum Institute to launch dengue vaccine in South America next year
The country’s largest vaccine manufacturer, Serum Institute of India, will be launching its dengue vaccine in South America next year, as the company prepares to file for regulatory approvals in…
Four-member body comes into being to revamp Maharashtra Medical Council Act
MMC wants to be able to take strict action against unethical practices at healthcare insts across state Over five decades after the Maharashtra Medical Council (MMC) Act, 1965, came into…
Besides treatment of cancer, quality of life is equally important: Dr Trinanjan Basu
Shahid Akhter, editor, ETHealthworld spoke to Dr Trinanjan Basu, consultant radiation oncologist, HCG Apex Cancer Centre, Mumbai, to know more about trends and challenges in Geriatric Oncology. How does cancer…
CAM inks MoU for Ayushman Bharat
Vadodara/Anand: Karamsad-based Charutar Arogya Mandal (CAM) has signed a MoU with National Health Systems Resource Centre (NHSRC) of the State Health Society, Gujarat for providing technical support for implementing Ayushman…
WHO announces important changes to multi drug resistant TB treatment
MUMBAI: Ahead of the first-ever United Nations High level Meeting next month, the World Health Organisation on Friday announced crucial changes to the multi drug resistant TB treatment regimen, which…
AstraZeneca Pharma India gets DCGI nod to market cancer drug in India
New Delhi: Drug firm AstraZeneca Pharma India today said it has received permission from the Drug Controller General of India (DCGI) to import and market olaparib tablets used for the…
